Stock data
Lifecore Biomedical, Inc. (LFCR)
Lifecore Biomedical, Inc. (LFCR) reported net income of -US$38.72M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-05-25
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | US$40.30M | -US$17.25M | -US$38.72M | — |
| 2024 | — | US$41.85M | -US$8.84M | US$12.01M | — |
| 2023 | — | US$27.98M | -US$21.80M | -US$99.56M | — |
| 2022 | — | US$39.07M | -US$11.79M | -US$116.72M | — |
| 2021 | — | US$38.94M | -US$8.82M | -US$32.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$6.16M | — |
| 2026-03-31 | — | -US$14.98M | — |
| 2025-09-30 | — | -US$9.99M | — |
| 2025-05-25 | — | -US$1.15M | — |
| 2025-02-23 | — | -US$14.77M | — |
| 2024-11-24 | — | -US$6.57M | — |
| 2024-08-25 | — | -US$16.23M | — |
| 2024-05-26 | — | -US$7.08M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.